NCT01000207View on ClinicalTrials.gov

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Swine-Origin Influenza A H1N1 Virus
Interventions
BIOLOGICAL

Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine

High dose group and low dose group of adjuvanted vaccines

Trial Locations (1)

Unknown

Sites 1,2,3,4,5, Kagoshima

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY